Genmab Stock (OTC:GNMSF), Analyst Ratings, Price Targets, Predictions
Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Analyst Ratings for Genmab
No data available to display
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|
FAQ
What is the target price for Genmab (GNMSF)?
There is no price target for Genmab.
What is the most recent analyst rating for Genmab (GNMSF)?
There is no analyst for Genmab.
When was the last upgrade for Genmab (GNMSF)?
There is no last upgrade for Genmab.
When was the last downgrade for Genmab (GNMSF)?
There is no last downgrade for Genmab.
When is the next analyst rating going to be posted or updated for Genmab (GNMSF)?
There is no next analyst rating for Genmab.
Is the Analyst Rating Genmab (GNMSF) correct?
There is no next analyst rating for Genmab.
Browse analyst ratings and price targets on all stocks.